Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

Oral colon-release parnaparin sodium tablets are safe and effective as an adjunctive therapy to aminosalicylates in patients with ulcerative colitis, according to a recently published clinical trial.

Ulcerative colitis is a type of chronic inflammatory bowel disease that causes painful ulcers and irritation in the large intestine. In North America alone, it is estimated to affect more than ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

Ulcerative colitis is a type of inflammatory bowel disease that causes inflammation in the colon. This leads to flare-ups that can trigger bowel movement changes, cramping and tenderness ...

DelveInsight’s, “Ulcerative Colitis Pipeline Insight 2025” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis Pipeline Landscape.

With over 250 peer-reviewed publications, he has made significant contributions to medical literature, shedding light on the treatment and understanding of ulcerative colitis and Crohn's disease.